1. Developmental Biology
  2. Neuroscience

Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival

  1. Eleni Kougioumtzidou
  2. Takahiro Shimizu
  3. Nicola B Hamilton
  4. Koujiro Tohyama
  5. Rolf Sprengel
  6. Hannah Monyer
  7. David Attwell  Is a corresponding author
  8. William D Richardson  Is a corresponding author
  1. University College London, United Kingdom
  2. Iwate Medical University, Japan
  3. University of Heidelberg, Germany
https://doi.org/10.7554/eLife.28080
Share this article
Cite this article
  1. Eleni Kougioumtzidou
  2. Takahiro Shimizu
  3. Nicola B Hamilton
  4. Koujiro Tohyama
  5. Rolf Sprengel
  6. Hannah Monyer
  7. David Attwell
  8. William D Richardson
(2017)
Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival
eLife 6:e28080.
https://doi.org/10.7554/eLife.28080
  2. Download BibTeX
  3. Download .RIS

Abstract

Myelin, made by oligodendrocytes, is essential for rapid information transfer in the central nervous system. Oligodendrocyte precursors (OPs) receive glutamatergic synaptic input from axons but how this affects their development is unclear. Murine OPs in white matter express AMPA receptor (AMPAR) subunits GluA2, GluA3 and GluA4. We generated mice in which OPs lack both GluA2 and GluA3, or all three subunits GluA2/3/4, which respectively reduced or abolished AMPAR-mediated input to OPs. In both double- and triple-knockouts OP proliferation and number were unchanged but ~25% fewer oligodendrocytes survived in the subcortical white matter during development. In triple knockouts, this shortfall persisted into adulthood. The oligodendrocyte deficit resulted in ~20% fewer myelin sheaths but the average length, number and thickness of myelin internodes made by individual oligodendrocytes appeared normal. Thus, AMPAR-mediated signalling from active axons stimulates myelin production in developing white matter by enhancing oligodendrocyte survival, without influencing myelin synthesis per se.

Article and author information

Author details

  1. Eleni Kougioumtzidou

    Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

  2. Takahiro Shimizu

    Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

  3. Nicola B Hamilton

    Department of Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

  4. Koujiro Tohyama

    The Center for Electron Microscopy and Bio-Imaging Research, Iwate Medical University, Morioka, Japan
    Competing interests
    The authors declare that no competing interests exist.

  5. Rolf Sprengel

    Institute for Anatomy and Cell Biology, University of Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  6. Hannah Monyer

    Department of Clinical Neurobiology, University of Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  7. David Attwell

    Department of Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom
    For correspondence
    d.attwell@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3618-0843

  8. William D Richardson

    Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
    For correspondence
    w.richardson@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7261-2485

Funding

Wellcome (100269/Z/12/Z)

  • William D Richardson

Japan Society for the Promotion of Science (24650181)

  • Koujiro Tohyama

Wellcome (108726/Z/15/Z)

  • William D Richardson

Wellcome (099222/Z/12/Z)

  • David Attwell

Wellcome (089591/Z/09/Z)

  • Eleni Kougioumtzidou

European Research Council (293544)

  • William D Richardson

German Research Foundation (SFB636/A4)

  • Rolf Sprengel

German Research Foundation (SFB1134/B01)

  • Rolf Sprengel

German Research Foundation (SFB 1158/A05)

  • Rolf Sprengel

Japan Society for the Promotion of Science (25245069)

  • Koujiro Tohyama

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were pre-approved by the UCL Ethical Committee and authorized by the Home Office of the UK Government in accordance with Animals (Scientific Procedures) Act 1986., under Project Licences PPL 70/7299 and PPL 70/8976 (D. Attwell) and PPL 70/7614 (W.D. Richardson).

Copyright

© 2017, Kougioumtzidou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,037
    views
  • 831
    downloads
  • 111
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eleni Kougioumtzidou
  2. Takahiro Shimizu
  3. Nicola B Hamilton
  4. Koujiro Tohyama
  5. Rolf Sprengel
  6. Hannah Monyer
  7. David Attwell
  8. William D Richardson
(2017)
Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival
eLife 6:e28080.
https://doi.org/10.7554/eLife.28080

Share this article

https://doi.org/10.7554/eLife.28080

Categories and tags

Research organism

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine

    Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells

    Olivia B Taylor, Nicholas DeGroff ... Andy J Fischer
    Research Article

    The purpose of these studies is to investigate how Sphingosine-1-phosphate (S1P) signaling regulates glial phenotype, dedifferentiation of Müller glia (MG), reprogramming into proliferating MG-derived progenitor cells (MGPCs), and neuronal differentiation of the progeny of MGPCs in the chick retina. We found that S1P-related genes are highly expressed by retinal neurons and glia, and levels of expression were dynamically regulated following retinal damage. Drug treatments that activate S1P receptor 1 (S1PR1) or increase levels of S1P suppressed the formation of MGPCs. Conversely, treatments that inhibit S1PR1 or decrease levels of S1P stimulated the formation of MGPCs. Inhibition of S1P receptors or S1P synthesis significantly enhanced the neuronal differentiation of the progeny of MGPCs. We report that S1P-related gene expression in MG is modulated by microglia and inhibition of S1P receptors or S1P synthesis partially rescues the loss of MGPC formation in damaged retinas missing microglia. Finally, we show that TGFβ/Smad3 signaling in the resting retina maintains S1PR1 expression in MG. We conclude that the S1P signaling is dynamically regulated in MG and MGPCs in the chick retina, and activation of S1P signaling depends, in part, on signals produced by reactive microglia.

    1. Developmental Biology

    Impaired yolk sac NAD metabolism disrupts murine embryogenesis with relevance to human birth defects

    Kayleigh Bozon, Hartmut Cuny ... Sally L Dunwoodie
    Research Article

    Congenital malformations can originate from numerous genetic or non-genetic factors but in most cases the causes are unknown. Genetic disruption of nicotinamide adenine dinucleotide (NAD) de novo synthesis causes multiple malformations, collectively termed Congenital NAD Deficiency Disorder (CNDD), highlighting the necessity of this pathway during embryogenesis. Previous work in mice shows that NAD deficiency perturbs embryonic development specifically when organs are forming. While the pathway is predominantly active in the liver postnatally, the site of activity prior to and during organogenesis is unknown. Here, we used a mouse model of human CNDD and assessed pathway functionality in embryonic livers and extraembryonic tissues via gene expression, enzyme activity and metabolic analyses. We found that the extra-embryonic visceral yolk sac endoderm exclusively synthesises NAD de novo during early organogenesis before the embryonic liver takes over this function. Under CNDD-inducing conditions, visceral yolk sacs had reduced NAD levels and altered NAD-related metabolic profiles, affecting embryo metabolism. Expression of requisite pathway genes is conserved in the equivalent yolk sac cell type in humans. Our findings show that visceral yolk sac-mediated NAD de novo synthesis activity is essential for mouse embryogenesis and its perturbation causes CNDD. As mouse and human yolk sacs are functionally homologous, our data improve the understanding of human congenital malformation causation.

    1. Developmental Biology

    Morphogenesis: Fluid transport comes to the fore

    Yufei Wu, Sean X Sun
    Insight

    Proteins that allow water to move in and out of cells help shape the development of new blood vessels.